/
/
/

Alkem Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014
₹3740 Cr₹3603 Cr₹3737 Cr₹4001 Cr₹3371 Cr₹3144 Cr₹3374 Cr₹3415 Cr₹3032 Cr₹2936 Cr₹3324 Cr₹3440 Cr₹2968 Cr₹2903 Cr₹3041 Cr₹3079 Cr₹2576 Cr₹2484 Cr₹2619 Cr₹2800 Cr₹2731 Cr₹2192 Cr₹2318 Cr₹2363 Cr₹1992 Cr₹2049 Cr₹2182 Cr₹2264 Cr₹1850 Cr₹1853 Cr₹1926 Cr₹1919 Cr₹1659 Cr₹1492 Cr₹1741 Cr₹1859 Cr₹1313 Cr₹1251 Cr₹1482 Cr₹1638 Cr₹1481 Cr₹1149 Cr₹1288 Cr₹1382 Cr₹1208 Cr₹912 Cr₹988 Cr
₹153 Cr₹200 Cr₹143 Cr₹104 Cr₹136 Cr₹146 Cr₹93 Cr₹134 Cr₹120 Cr₹88 Cr₹94 Cr₹63 Cr₹66 Cr₹69 Cr₹45 Cr₹51 Cr₹51 Cr₹21 Cr₹54 Cr₹42 Cr₹47 Cr₹46 Cr₹96 Cr₹36 Cr₹55 Cr₹27 Cr₹28 Cr₹31 Cr₹17 Cr₹29 Cr₹8 Cr₹25 Cr₹27 Cr₹29 Cr₹24 Cr₹30 Cr₹29 Cr₹25 Cr₹25 Cr₹34 Cr₹28 Cr₹104 Cr₹18 Cr₹70 Cr₹48 Cr₹51 Cr₹39 Cr
₹3893 Cr₹3803 Cr₹3880 Cr₹4105 Cr₹3508 Cr₹3290 Cr₹3467 Cr₹3549 Cr₹3152 Cr₹3024 Cr₹3418 Cr₹3503 Cr₹3034 Cr₹2971 Cr₹3086 Cr₹3130 Cr₹2628 Cr₹2504 Cr₹2673 Cr₹2842 Cr₹2778 Cr₹2238 Cr₹2414 Cr₹2398 Cr₹2047 Cr₹2076 Cr₹2210 Cr₹2295 Cr₹1867 Cr₹1882 Cr₹1934 Cr₹1943 Cr₹1686 Cr₹1521 Cr₹1765 Cr₹1889 Cr₹1342 Cr₹1276 Cr₹1507 Cr₹1672 Cr₹1509 Cr₹1252 Cr₹1306 Cr₹1452 Cr₹1255 Cr₹962 Cr₹1027 Cr
₹3074 Cr₹3192 Cr₹3004 Cr₹3174 Cr₹2720 Cr₹2865 Cr₹2700 Cr₹2741 Cr₹2504 Cr₹2617 Cr₹2686 Cr₹2767 Cr₹2651 Cr₹2628 Cr₹2520 Cr₹2703 Cr₹2449 Cr₹2230 Cr₹2198 Cr₹2248 Cr₹2209 Cr₹1970 Cr₹1858 Cr₹1833 Cr₹1537 Cr₹1827 Cr₹1788 Cr₹1868 Cr₹1641 Cr₹1676 Cr₹1660 Cr₹1601 Cr₹1498 Cr₹1429 Cr₹1418 Cr₹1439 Cr₹1249 Cr₹1129 Cr₹1240 Cr₹1353 Cr₹1233 Cr₹1017 Cr₹1075 Cr₹1152 Cr₹1022 Cr₹795 Cr₹838 Cr
₹919 Cr₹717 Cr₹971 Cr₹1024 Cr₹876 Cr₹537 Cr₹852 Cr₹887 Cr₹729 Cr₹490 Cr₹801 Cr₹810 Cr₹455 Cr₹422 Cr₹644 Cr₹505 Cr₹255 Cr₹358 Cr₹552 Cr₹666 Cr₹640 Cr₹337 Cr₹626 Cr₹636 Cr₹577 Cr₹331 Cr₹481 Cr₹484 Cr₹282 Cr₹263 Cr₹321 Cr₹388 Cr₹230 Cr₹132 Cr₹384 Cr₹484 Cr₹124 Cr₹174 Cr₹294 Cr₹344 Cr₹299 Cr₹259 Cr₹254 Cr₹326 Cr₹254 Cr₹185 Cr₹210 Cr
₹47 Cr₹54 Cr₹42 Cr₹35 Cr₹30 Cr₹28 Cr₹36 Cr₹28 Cr₹29 Cr₹27 Cr₹25 Cr₹30 Cr₹30 Cr₹29 Cr₹27 Cr₹25 Cr₹27 Cr₹17 Cr₹11 Cr₹12 Cr₹13 Cr₹11 Cr₹13 Cr₹18 Cr₹17 Cr₹14 Cr₹17 Cr₹18 Cr₹16 Cr₹7 Cr₹15 Cr₹16 Cr₹16 Cr₹10 Cr₹14 Cr₹18 Cr₹13 Cr₹11 Cr₹12 Cr₹12 Cr₹10 Cr₹10 Cr₹18 Cr₹20 Cr₹22 Cr₹17 Cr₹21 Cr
₹772 Cr₹423 Cr₹781 Cr₹896 Cr₹771 Cr₹396 Cr₹731 Cr₹780 Cr₹619 Cr₹367 Cr₹655 Cr₹648 Cr₹353 Cr₹212 Cr₹539 Cr₹402 Cr₹152 Cr₹243 Cr₹464 Cr₹582 Cr₹556 Cr₹258 Cr₹543 Cr₹548 Cr₹493 Cr₹235 Cr₹405 Cr₹410 Cr₹210 Cr₹199 Cr₹258 Cr₹326 Cr₹172 Cr₹81 Cr₹332 Cr₹432 Cr₹81 Cr₹136 Cr₹255 Cr₹307 Cr₹266 Cr₹225 Cr₹213 Cr₹280 Cr₹211 Cr₹150 Cr₹168 Cr
₹521 Cr₹252 Cr₹654 Cr₹780 Cr₹668 Cr₹323 Cr₹641 Cr₹702 Cr₹550 Cr₹304 Cr₹604 Cr₹615 Cr₹288 Cr₹68 Cr₹460 Cr₹348 Cr₹131 Cr₹108 Cr₹533 Cr₹559 Cr₹480 Cr₹249 Cr₹464 Cr₹482 Cr₹423 Cr₹192 Cr₹390 Cr₹381 Cr₹187 Cr₹171 Cr₹205 Cr₹260 Cr₹137 Cr₹66 Cr₹181 Cr₹327 Cr₹64 Cr₹137 Cr₹236 Cr₹288 Cr₹243 Cr₹87 Cr₹190 Cr₹272 Cr₹204 Cr₹132 Cr₹161 Cr

Share Price Live Stats

Open (₹)5,190.00
Volume (₹)23,241.00
High (₹)5,210.00
Upper Circuit5,712.00
Low (₹)5,130.00
Lower Circuit4,674.00
Prev Close5,193.00
52W High (₹)5,933.50
Price5,177.50
52W Low (₹)5,075.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)61994.50 Cr
Div. Yield (%)1.02
PE Ratio28.73
Debt to Equity0.12
Price to Book4.60
Book Value1,153.04
EPS (TTM)180.45
Face Value2.00
ROE (%)18.29

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ALKEMNSE
LTP
1W Low
1W High
Market cap (₹)
1905.3-14.7 (-0.77%)
1902
1984.80
4,56,833Cr
9210-29 (-0.31%)
9087
9467
2,45,426Cr
4890-160 (-3.17%)
4885
5066
1,87,320Cr
1133.6-57.4 (-4.82%)
1125.10
1187
1,13,217Cr
1390.6-32.9 (-2.31%)
1376.70
1426.10
1,12,212Cr
1853.3-85.2 (-4.40%)
1811.70
1949
1,01,155Cr
2123-48.5 (-2.23%)
2118.10
2192
97,626Cr
2347.9-35 (-1.47%)
2341.20
2419.20
96,859Cr
1163.8-14.2 (-1.21%)
1154.40
1179.90
96,406Cr
1655.6+10.3 (0.63%)
1622.60
1717
93,614Cr
5177.5-177.5 (-3.31%)
5130
5378.50
61,995Cr

Key Highlights of Alkem Laboratories Ltd’s P&L

In 2026-03-31, Alkem Laboratories Ltd reported total revenue of ₹15306.56Cr, compared with ₹13458.24Cr in 2025-03-31, reflecting Alkem Laboratories Ltd turnover.

Depreciation was ₹382.06Cr and finance costs were ₹160.78Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹2870.89Cr in 2026-03-31 as compared to ₹2527.03Cr in 2025-03-31.

Net Profit (PAT) was ₹2301.8Cr in 2026-03-31 compared with ₹2165.48Cr in 2025-03-31.

Earnings per share (EPS) were ₹192.54 in 2026-03-31, compared with ₹181.14 in 2025-03-31.